NCT06590181 Comparing the Effects of Yoga Nidra to Yoga Nidra With Pain Acceptance Intention and Motor Imagery on Pain Outcomes
| NCT ID | NCT06590181 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-09-12 |
| Primary Completion | 2025-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-09-12 with a primary completion date of 2025-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Yoga Nidra is a scripted mind-body intervention (MBI) that uses guided relaxation technique in a reproducible sequence of mechanisms that naturally produce a parasympathetic response. This is a randomized controlled trial in which participants will be randomly assigned to one of three interventions: 1) yoga nidra (Yoga Nidra Script Basic), 2) yoga nidra with pain acceptance (Yoga Nidra Acceptance Intention), 3) yoga nidra with pain acceptance and Explicit Motor Imagery (Yoga Nidra Acceptance Intention and Visualization).
Eligibility Criteria
Inclusion Criteria: * Chronic pain in the neck, low back, shoulder, hip, elbow, knee, wrist, or ankle that has lasted for over three months * Pain intensity rated as 3/10 or higher in the past 24 hours (0=no pain, 10=worst pain imaginable) Exclusion Criteria: * non-English speaking * systemic medical conditions that affect sensation (such as uncontrolled diabetes) * History of surgery or fracture within the past six months * any blood clotting disorders (such as hemophilia) * any contraindication to the application of ice (blood pressure \> 140/90 mmHg, cold urticaria, cryoglobulinemia, paroxysmal cold hemoglobinuria, circulatory compromise) * Exceed pressure and heat sensory thresholds * Unable to access internet or email * Pregnant
Contact & Investigator
Abigail Anderson, PT, DPT, PhD
PRINCIPAL INVESTIGATOR
University of Central Florida
Frequently Asked Questions
Who can join the NCT06590181 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06590181 currently recruiting?
Yes, NCT06590181 is actively recruiting participants. Contact the research team at Abigail.Wilson@ucf.edu for enrollment information.
Where is the NCT06590181 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT06590181 clinical trial?
NCT06590181 is sponsored by University of Central Florida. The principal investigator is Abigail Anderson, PT, DPT, PhD at University of Central Florida. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.